Treatment-resistant depression

Ketamine and esketamine have strong emerging evidence for rapid symptom relief in TRD. TMS has moderate-to-strong support. ECT remains the most robustly evidenced intervention for severe cases. Adjunctive approaches — including exercise, omega-3 supplementation, nutritional psychiatry, and acupuncture — show supporting evidence but have been studied primarily as additions to primary psychiatric treatment, not as standalone options.

Clinically, TRD involves persistent depressive episodes despite two or more antidepressant treatments at adequate doses and duration. It is associated with higher rates of comorbidity, greater functional impairment, and elevated suicide risk. Neurobiological factors — including reduced neuroplasticity, neuroinflammation, and HPA axis dysregulation — may contribute to why standard pharmacological approaches do not produce adequate relief for some people.

Somatic therapy, mindfulness, yoga, breathwork, acupuncture, and nutritional approaches each have varying levels of supporting evidence in depression broadly, with more limited data specific to TRD. These are best understood as potentially supportive additions to — not substitutes for — specialist psychiatric management. Discussing any complementary approach with your treating clinician helps ensure safe integration.

Active suicidal thoughts, a plan or intent to act on them, escalating self-harm, psychotic symptoms, or an inability to care for yourself are situations requiring urgent professional support. If you or someone you know is experiencing any of these, contact a crisis line, emergency services, or a mental health professional immediately. Do not rely on any self-directed or complementary approach in these circumstances.

People with TRD should not stop or adjust prescribed psychiatric medications without guidance from a qualified clinician. Sole reliance on complementary or lifestyle approaches — without maintaining specialist psychiatric oversight — is not appropriate for this condition. TRD carries elevated risk, and any changes to a treatment plan should be made collaboratively with a treating professional.

A psychiatrist or specialist mental health team should remain central to TRD management. Integrative or complementary practitioners working with someone who has TRD should be informed of the full clinical picture and work collaboratively within that context. Gyfts supports discovery of qualified practitioners but does not provide professional assessment, and nothing here substitutes for individualised specialist care.